BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5165306)

  • 21. [Introduction and application of CSF cytology for diagnosis and treatment of central nervous system diseases].
    Su XC; Zhao G; Yang YN; Deng YC
    Acta Neurol Taiwan; 2006 Jun; 15(2):143-8. PubMed ID: 16871902
    [No Abstract]   [Full Text] [Related]  

  • 22. [Quantitative determination of GPT, GOT and LDH in the cerebrospinal fluid as an aid in the diagnosis of the kind of neurologic disease].
    Braun H; Ley H
    Munch Med Wochenschr; 1966 Aug; 108(32):1562-6. PubMed ID: 6014384
    [No Abstract]   [Full Text] [Related]  

  • 23. Fluorometric determination of pyruvate and alpha-ketoglutarate in cerebrospinal fluid and plasma of infants and children. A simple test that screen for metabolic disorders.
    Thurston JH; Hauhart RE; Seltzer JL; McDougal DB
    Arch Neurol; 1976 Nov; 33(11):764-8. PubMed ID: 985154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose interferes in fluorometry of serum citrate in diabetic patients with hyperglycemia.
    Kobayashi K; Katsumoto H; Murakoso K; Matsuoka A
    Clin Chem; 1987 Oct; 33(10):1940. PubMed ID: 3665059
    [No Abstract]   [Full Text] [Related]  

  • 25. [Progressive muscular dystrophy. Metabolic studies, adrenaline tolerance test].
    Moser K; Sluga E; Lujf A
    Wien Klin Wochenschr; 1970 Mar; 82(11):187-92. PubMed ID: 5513468
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical and experimental studies on xylitol - with special reference to blood sugar, insulin, pyruvic acid, lactic acid and alpha-ketoglutaric acid].
    Fujisawa M
    Igaku Kenkyu; 1968 Feb; 38(1):105-22. PubMed ID: 5692607
    [No Abstract]   [Full Text] [Related]  

  • 27. Blood pyruvate and alpha-ketoglutarate in normal and diabetic subjects.
    SMITH MJ; TAYLOR KW
    Br Med J; 1956 Nov; 2(5000):1035-8. PubMed ID: 13364382
    [No Abstract]   [Full Text] [Related]  

  • 28. [Levels of Krebs cycle metabolites in the blood and urine of patients with diabetes mellitus].
    Efimov AS; Gulyĭ MF; Shcherbak AV; Dzvonkevich ND
    Probl Endokrinol (Mosk); 1983; 29(2):10-4. PubMed ID: 6856592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid electrolyte disturbances in neurological disorders: with special reference to inorganic phosphate.
    Breyer U; Kanig K
    Neurology; 1970 Mar; 20(3):247-53. PubMed ID: 5461053
    [No Abstract]   [Full Text] [Related]  

  • 30. [Some considerations apropos of glycorrhachia in clinical neuropathology].
    RODRIGUEZ-ARIAS B; LAMOTE DE GRIGNON C
    Rev Clin Esp; 1962 May; 85():177-83. PubMed ID: 14493209
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of hormones on glucose metabolism in man. 3. Blood citric acid and its response to glucose load in normal subjects and patients with various endocrine disorders].
    Morita T
    Naika Hokan; 1971 Jul; 18(7):237-51. PubMed ID: 5165955
    [No Abstract]   [Full Text] [Related]  

  • 32. Update on central nervous system cytopathology. I. Cerebrospinal fluid.
    Bell JE
    J Clin Pathol; 1994 Jul; 47(7):573-8. PubMed ID: 8089208
    [No Abstract]   [Full Text] [Related]  

  • 33. A study of citrate levels in C.S.F. and serum in cases of meningitis and cerebrovascular accidents.
    Pal R; Rishi JP; Mathur US; Sharma BM
    J Assoc Physicians India; 1983 Jul; 31(7):439-40. PubMed ID: 6654808
    [No Abstract]   [Full Text] [Related]  

  • 34. Adenosine deaminase in cerebrospinal fluid.
    Hankiewicz J; Lesniak M
    Enzymologia; 1972 Dec; 43(6):385-95. PubMed ID: 4646287
    [No Abstract]   [Full Text] [Related]  

  • 35. [The behavior of the cerebrospinal fluid sugar following glucose load with special reference to diabetic polyneuropathy].
    Tschabitscher H; Heiss WD; Pernhaupt G; Prosenz P
    Wien Klin Wochenschr; 1967 Dec; 79(49):922-4. PubMed ID: 5591995
    [No Abstract]   [Full Text] [Related]  

  • 36. 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of patients with neurological diseases.
    Johannsson B; Roos BE
    Eur Neurol; 1974; 11(1):37-45. PubMed ID: 4363875
    [No Abstract]   [Full Text] [Related]  

  • 37. [The acid-base status in the cerebrospinal fluid in neuropsychiatric diseases].
    Kluge H; Zahlten W; Ring U; Freesmeyer E; Schock G; Mühlau G; Wieczorek V; Hartmann W
    Z Med Lab Diagn; 1978 Dec; 19(6):363-71. PubMed ID: 746685
    [No Abstract]   [Full Text] [Related]  

  • 38. Citric, orotic, and other organic acids in rats injected with active or inactive urease.
    Prior RL; Zimber A; Visek WJ
    Am J Physiol; 1975 Mar; 228(3):828-33. PubMed ID: 1115248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [THE EFFECT OF BLOOD SUGAR CHANGES ON INTERMEDIATE METABOLISM IN PATIENTS WITH ASTHENIC NEUROSES. II. EFFECT OF TREATMENT WITH INCREASING DOSES OF INSULIN].
    PINTILIE C; COSTA-FORU D; MISON-CRIGHEL N; CONSTANTINESCU E; LUCA N; SOLOMONOVICI A
    Rev Sci Med; 1963; 8():159-62. PubMed ID: 14109304
    [No Abstract]   [Full Text] [Related]  

  • 40. CHANGES IN THE BLOOD CONCENTRATION OF GLUCOSE, ALPHA-OXOGLUTARATE, PYRUVATE AND CITRATE DURING EXCHANGE TRANSFUSION IN HAEMOLYTIC DISEASE OF THE NEWBORN.
    ANDERSON J; MARKS V; TOMLINSON RW; WALKER W
    Arch Dis Child; 1963 Oct; 38(201):481-4. PubMed ID: 14065991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.